A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.

[1]  D. Montefiori,et al.  Replicating Rather than Nonreplicating Adenovirus-Human Immunodeficiency Virus Recombinant Vaccines Are Better at Eliciting Potent Cellular Immunity and Priming High-Titer Antibodies , 2005, Journal of Virology.

[2]  D. Venzon,et al.  Vaccine-Elicited Antibodies Mediate Antibody-Dependent Cellular Cytotoxicity Correlated with Significantly Reduced Acute Viremia in Rhesus Macaques Challenged with SIVmac2511 , 2005, The Journal of Immunology.

[3]  D. Venzon,et al.  Protection against Mucosal Simian Immunodeficiency Virus SIVmac251 Challenge by Using Replicating Adenovirus-SIV Multigene Vaccine Priming and Subunit Boosting , 2004, Journal of Virology.

[4]  Tetsuya Nakamura,et al.  Antibody-Dependent Cellular Cytotoxicity via Humoral Immune Epitope of Nef Protein Expressed on Cell Surface1 , 2004, The Journal of Immunology.

[5]  J. Vincelette,et al.  Evidence for a Correlation Between Antibody-Dependent Cellular Cytotoxicity-Mediating Anti-HIV-1 Antibodies and Prognostic Predictors of HIV Infection , 2001, Journal of Clinical Immunology.

[6]  D. Venzon,et al.  Potent, Persistent Induction and Modulation of Cellular Immune Responses in Rhesus Macaques Primed with Ad5hr-Simian Immunodeficiency Virus (SIV) env/rev, gag, and/or nef Vaccines and Boosted with SIV gp120 , 2003, Journal of Virology.

[7]  H. Mellstedt.  Monoclonal antibodies in human cancer. , 2003, Drugs of today.

[8]  J. Clements,et al.  Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS. , 2002, AIDS research and human retroviruses.

[9]  F. Eko,et al.  Fc receptor regulation of protective immunity against Chlamydia trachomatis , 2002, Immunology.

[10]  D. Evans,et al.  Flow cytometry-based assay for determination of teleost cytotoxic cell lysis of target cells. , 2001, Cytometry.

[11]  R. Wilkinson,et al.  Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores. , 2001, Journal of immunological methods.

[12]  S. Seki,et al.  Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells , 2001, Immunology.

[13]  G. Landucci,et al.  Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count. , 2001, AIDS research and human retroviruses.

[14]  P. Klenerman,et al.  A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. , 2001, Journal of immunological methods.

[15]  Z. Entezami,et al.  ENUMERATION OF PERIPHERAL BLOOD LYMPHOCYTE SUBSETS IN A HEALTHY IRANIAN POPULATION , 2001 .

[16]  Y. Xu,et al.  Protective immunity induced by the full-length cDNA encoding paramyosin of Chinese Schistosoma japonicum. , 2000, Vaccine.

[17]  D. Scheinberg,et al.  Monoclonal antibody therapies–a ‘constant’ threat to cancer , 2000, Nature Medicine.

[18]  R. Sekulovich,et al.  Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine. , 2000, The Journal of infectious diseases.

[19]  Ali Ahmad,et al.  Antibody‐dependent cellular cytotoxicity in HIV infections , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  A. Trkola,et al.  Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 , 1996, Journal of virology.

[21]  R. Montelaro,et al.  Analysis of envelope glycoprotein-specific antibodies from SIV-infected and gp110-immunized monkeys in ACC and ADCC assays. , 1995, AIDS research and human retroviruses.

[22]  C. Nilsson,et al.  Broadly reactive HIV-2 and SIVmac specific antibody-dependent cellular cytotoxicity in immunized and infected cynomolgus monkeys. , 1994, Vaccine.

[23]  C. Garbe,et al.  A rapid and sensitive fluorometric microassay for determining cell mediated cytotoxicity to adherent growing cell lines. , 1992, Journal of immunological methods.

[24]  M. Wainberg,et al.  Role of Antibody‐Dependent Cellular Cytotoxicity and Lymphokine‐Activated Killer Cells in AIDS and Related Diseases , 1991, Journal of leukocyte biology.

[25]  S. Kohl.  Role of antibody-dependent cellular cytotoxicity in neonatal infection with herpes simplex virus. , 1991, Reviews of infectious diseases.

[26]  T. Matthews,et al.  Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors , 1991 .

[27]  M. Gershwin,et al.  Natural killer cell activity of rhesus macaques against retrovirus-pulsed CD4+ target cells. , 1990, AIDS research and human retroviruses.

[28]  J. Bartlett,et al.  Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects. , 1990, Journal of immunology.

[29]  B. Walker,et al.  Techniques in HIV Research , 1990, Palgrave Macmillan UK.

[30]  T. Copeland,et al.  Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. , 1990, AIDS research and human retroviruses.

[31]  R. M. Hendry,et al.  Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection. , 1990, AIDS research and human retroviruses.

[32]  K. Weinhold.  Nonrestricted Forms of Anti-HIV-1 Cytotoxicity , 1990 .

[33]  D. Tyler,et al.  Minireview Anti-HIV-1 ADCC , 1989 .

[34]  H. Mohr,et al.  A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity. , 1989, Journal of immunological methods.

[35]  P. Horan,et al.  Cell-mediated cytotoxicity. A highly sensitive and informative flow cytometric assay. , 1989, Journal of immunological methods.

[36]  A J Langlois,et al.  Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Robert-Guroff,et al.  HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemia. , 1987, Journal of immunology.

[38]  P. Wright,et al.  Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. , 1983, The Journal of infectious diseases.